Pesquisar
eXoZymes Inc
EXOZAdicionar à lista de desejos
6.380USD
+0.190+3.07%
Fechamento 09-23 16:00（ET）
59.21MValor de mercado
PerdaP/L TTM
Sobre o eXoZymes Inc Empresa
eXoZymes Inc, formerly Invizyne Technologies, Inc., is an artificial intelligence (AI) engineered enzyme that can transform sustainable feedstock into essential chemicals, medicines, and biofuels. The Company has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
eXoZymes Inc Perfil
Código da empresaEXOZ
Nome da EmpresaeXoZymes Inc
Data de listagemNov 13, 2024
CEOHeltzen (Michael)
Número de funcionários31
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 13
Endereço750 Royal Oaks Dr
CidadeMONROVIA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal91016
Telefone16264151488
Sitehttps://exozymes.com/
Código da empresaEXOZ
Data de listagemNov 13, 2024
CEOHeltzen (Michael)
Executivos da empresa eXoZymes Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
647.49K
+0.62%
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
647.49K
+0.62%
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
647.49K
+0.62%
Mr. Michael Heltzen
Mr. Michael Heltzen
Chief Executive Officer
Chief Executive Officer
9.70K
--
Mr. Michael Heltzen
Mr. Michael Heltzen
Chief Executive Officer
Chief Executive Officer
9.70K
--
Mr. Michael Heltzen
Mr. Michael Heltzen
Chief Executive Officer
Chief Executive Officer
9.70K
--
Mr. Fouad Nawaz
Mr. Fouad Nawaz
Vice President - Finance
Vice President - Finance
9.49K
+63.23%
Mr. Fouad Nawaz
Mr. Fouad Nawaz
Vice President - Finance
Vice President - Finance
9.49K
+63.23%
Mr. Fouad Nawaz
Mr. Fouad Nawaz
Vice President - Finance
Vice President - Finance
9.49K
+63.23%
Dr. Tyler Korman, Ph.D.
Dr. Tyler Korman, Ph.D.
Vice President - Research
Vice President - Research
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
647.49K
+0.62%
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
647.49K
+0.62%
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
647.49K
+0.62%
Mr. Michael Heltzen
Mr. Michael Heltzen
Chief Executive Officer
Chief Executive Officer
9.70K
--
Mr. Michael Heltzen
Mr. Michael Heltzen
Chief Executive Officer
Chief Executive Officer
9.70K
--
Mr. Michael Heltzen
Mr. Michael Heltzen
Chief Executive Officer
Chief Executive Officer
9.70K
--
Perguntas frequentes
Quem são os cinco principais acionistas de eXoZymes Inc?
Os cinco principais acionistas de eXoZymes Inc são: Dr. Paul Hideo Opgenorth, Ph.D.
Quantas instituições possuem ações da eXoZymes Inc (EXOZ)?
Em 2026Q1, 13 instituições possuíam ações da eXoZymes Inc, com valor de mercado aproximado de 94.24K, representando 1.11% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 16676.00.